Advertisement

Topics

Clinical Finance: The Most Precious Of The Necessary Evils

02:45 EST 27 Nov 2018 | eCliniqua

Clinical Informatics News | Clinical finance can sometimes be viewed as a necessary evil. Chris Chan, Executive Director, R&D Finance, at Fibrogen, discusses how clinical finance can improve trial timelines, the challenges of adjusting the clinical team’s goals, and how the Lord of the Rings factors into it all.


 
 
 
 

Original Article: Clinical Finance: The Most Precious Of The Necessary Evils

NEXT ARTICLE

More From BioPortfolio on "Clinical Finance: The Most Precious Of The Necessary Evils"

Advertisement
Quick Search
Advertisement
Advertisement